Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AIC100 |
Trade Name | |
Synonyms | AIC-100|AIC 100 |
Drug Descriptions |
AIC100 is a cell therapy consisting of T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting the intercellular adhesion molecule-1 (ICAM-1), and CD28, potentially leading to activation of inhibitory T cells, inhibition of cell proliferation and inhibition of tumor growth (PMID: 31337787, NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C173378 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AIC100 | AIC100 | 0 | 1 |